Coda Biotherapeutics is developing a cure for pain

If the researchers, executives and investors behind Coda Biotherapeutics have their way, one day soon there really could be a cure for pain. Co-founded by researchers Joseph Glorioso, from the University of Pittsburgh’s microbiology and molecular genetics department; and Dr. Nicholas Boulis, the founder of Emory’s Gene and Cell Therapy for Neurorestoration Laboratory; Coda uses gene therapies to treat neurological diseases starting with severe pain and epilepsy.
Learn more about your ad choices. Visit podcastchoices.com/adchoices